Financial reports
ARS
2023 FY
Annual report to shareholders
26 Mar 24
10-K
2023 FY
Annual report
25 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
4 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
10-K
2019 FY
Annual report
3 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2019 FY
Annual report
10 Mar 22
Current reports
8-K
Material Modifications to Rights of Security Holders
12 Mar 24
8-K
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
11 Mar 24
8-K
Entry into a Material Definitive Agreement
29 Dec 23
8-K
Entry into a Material Definitive Agreement
29 Dec 23
8-K
Lexicon Pharmaceuticals Reports Third Quarter 2023
8 Nov 23
8-K
Departure of Directors or Certain Officers
11 Oct 23
8-K
Lexicon Pharmaceuticals Reports Second Quarter 2023
3 Aug 23
8-K
Lexicon Elects Diane E. Sullivan to Board of Directors
31 Jul 23
8-K
Departure of Directors or Certain Officers
24 Jul 23
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
28 Jun 23
Registration and prospectus
S-3
Shelf registration
25 Mar 24
424B5
Prospectus supplement for primary offering
29 Dec 23
S-8
Registration of securities for employees
4 Aug 23
D
$72.22 mm in equity, sold $72.22 mm, 1 investor
20 Jun 23
424B5
Prospectus supplement for primary offering
1 Jun 23
FWP
Free writing prospectus
1 Jun 23
FWP
Free writing prospectus
31 May 23
424B5
Prospectus supplement for primary offering
31 May 23
D
$49.32M in equity, sold $42.89M, 2 investors
3 Aug 22
424B5
Prospectus supplement for primary offering
29 Jul 22
Proxies
DEFA14A
Additional proxy soliciting materials
26 Mar 24
DEF 14A
Definitive proxy
26 Mar 24
PRE 14A
Preliminary proxy
11 Mar 24
DEFA14A
Additional proxy soliciting materials
17 Mar 23
DEF 14A
Definitive proxy
17 Mar 23
DEF 14A
Definitive proxy
8 Apr 22
DEFA14A
Additional proxy soliciting materials
8 Apr 22
PRE 14A
Preliminary proxy
11 Mar 22
DEFA14A
Additional proxy soliciting materials
19 Mar 21
DEF 14A
Definitive proxy
19 Mar 21
Other
CT ORDER
Confidential treatment order
8 Jun 23
EFFECT
Notice of effectiveness
15 Sep 21
CORRESP
Correspondence with SEC
10 Sep 21
UPLOAD
Letter from SEC
12 Aug 21
EFFECT
Notice of effectiveness
19 Nov 19
CORRESP
Correspondence with SEC
15 Nov 19
UPLOAD
Letter from SEC
14 Nov 19
CT ORDER
Confidential treatment order
29 Apr 19
CT ORDER
Confidential treatment order
22 Jan 18
CT ORDER
Confidential treatment order
4 Dec 17
Ownership